+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Cara Therapeutics Inc (CARA) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Cara Therapeutics Inc (Cara Therapeutics) is a clinical-stage biotechnology company that develops novel therapeutics for pain and inflammation and pruritus. The company products include kappa receptor agonists and cannabinoid receptors. It offers products for therapeutic areas which include acute pain, chronic pain, neuropathic pain and pruritus. Cara Therapeutics develops analgesics g protein-coupled receptors which are class of membrane proteins, using its dimer screen technology. The company develops molecules at novel analgesic and anti-inflammatory targets using proprietary drug screening technology. It serves pharmaceutical and healthcare sectors. Cara Therapeutics is headquartered in Stamford, Connecticut, the US.

Cara Therapeutics Inc Key Recent Developments

Nov 02, 2017: Cara Therapeutics Reports Third Quarter 2017 Financial Results
Aug 03, 2017: Cara Therapeutics Reports Second Quarter 2017 Financial Results
Aug 01, 2017: Cara Therapeutics appoints Mani Mohindru as chief financial officer
May 04, 2017: Cara Therapeutics Reports First Quarter 2017 Financial Results
Mar 09, 2017: Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results

This comprehensive SWOT profile of Cara Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cara Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Cara Therapeutics Inc - Key Information
  • Cara Therapeutics Inc - Overview
  • Cara Therapeutics Inc - Key Employees
  • Cara Therapeutics Inc - Key Employee Biographies
  • Cara Therapeutics Inc - Key Operational Heads
  • Cara Therapeutics Inc - Major Products and Services
  • Cara Therapeutics Inc - History
  • Cara Therapeutics Inc - Company Statement
  • Cara Therapeutics Inc - Locations And Subsidiaries
  • Cara Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cara Therapeutics Inc - Business Description
  • Cara Therapeutics Inc - Corporate Strategy
  • Cara Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cara Therapeutics Inc - Strengths
  • Cara Therapeutics Inc - Weaknesses
  • Cara Therapeutics Inc - Opportunities
  • Cara Therapeutics Inc - Threats
  • Cara Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cara Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cara Therapeutics Inc, Key Information
  • Cara Therapeutics Inc, Key Ratios
  • Cara Therapeutics Inc, Share Data
  • Cara Therapeutics Inc, Major Products and Services
  • Cara Therapeutics Inc, History
  • Cara Therapeutics Inc, Key Employees
  • Cara Therapeutics Inc, Key Employee Biographies
  • Cara Therapeutics Inc, Key Operational Heads
  • Cara Therapeutics Inc, Other Locations
  • Cara Therapeutics Inc, Subsidiaries
  • Cara Therapeutics Inc, Key Manufacturing facilities
  • Cara Therapeutics Inc, Key Competitors
  • Cara Therapeutics Inc, SWOT Analysis
  • Cara Therapeutics Inc, Ratios based on current share price
  • Cara Therapeutics Inc, Annual Ratios
  • Cara Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cara Therapeutics Inc, Performance Chart
  • Cara Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3